Statistics for BioAtla, (id:6750 BCAB)

Valuation metrics

Market cap

67.20M

Enterprise value

16.29M

Trailing P/E (ttm)

-0.61

Forward P/E

-0.95

PEG ratio

-0.95

Price/Sales (ttm)

6.11

Price/Book (mrq)

2.93

Enterprise Value/Revenue

1.48

Enterprise Value/EBITDA

-0.19

Overview

Shares outstanding

48.35M

Float

37.48M

Shares short

4.87M

% Held by insiders

0.11%

% Held by institutions

0.43%

Average volume (10 days)

1.50M

Average volume (90 days)

Price summary

52-Week low

1.14

52-Week high

4.02

52-Week change

6.07%

Beta

1.02

50-Day moving average

1.90

200-Day moving average

2.13

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-102.46%

Operational effectiveness

Return on assets

-50.47%

Return on equity

-139.06%

Income statement

Revenue (ttm)

0.23

Revenue per share (ttm)

0.23

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-85,170,000.00

Net income to common (ttm)

-81,817,000.00

Diluted EPS (ttm)

-1.70

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

56.52M

Total cash per share (mrq)

1.17

Total debt (mrq)

1.25M

Total Debt/Equity (mrq)

5.45

Current ratio (mrq)

311.20%

Book value per share (mrq)

0.48

Cash flow

Cash flow statement

-85,075,000.00

Levered free cash flow (LFCF)

-56,728,876.00